Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: effects of lipophilicity and structure-activity relationships. 1998

C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
Institut de Chimie, Faculté de Sciences, Université de Neuchâtel, Avenue de Bellevaux 51, CH-2000 Neuchâtel, Switzerland.

A number of condensed pyridazines and pyrimidines were synthesized and tested for their monoamine oxidase-A (MAO-A) and MAO-B inhibitory activity. Their lipophilicity was examined by measuring partition coefficients and RP-HPLC capacity factors, revealing some peculiar electronic and conformational effects. Further insights were obtained by X-ray crystallography and a thermodynamic study of RP-HPLC retention. Structure-activity relations highlighted the main factors determining both selectivity and inhibitory potency. Thus, while most of the condensed pyridazines were reversible inhibitors of MAO-B with little or no MAO-A effects, the pyrimidine derivatives proved to be reversible and selective MAO-A inhibitors. Substituents on the diazine nucleus modulated enzyme inhibition. A QSAR analysis of X-substituted 3-X-phenyl-5H-indeno[1,2-c]pyridazin-5-ones showed lipophilicity to increase MAO-B and not MAO-A inhibitory activity.

UI MeSH Term Description Entries
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016014 Linear Models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression. Linear Regression,Log-Linear Models,Models, Linear,Linear Model,Linear Regressions,Log Linear Models,Log-Linear Model,Model, Linear,Model, Log-Linear,Models, Log-Linear,Regression, Linear,Regressions, Linear

Related Publications

C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
September 1995, Journal of medicinal chemistry,
C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
March 2008, Bioorganic & medicinal chemistry,
C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
September 1995, Biochemical pharmacology,
C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
August 1973, Journal of medicinal chemistry,
C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
September 1959, Annals of the New York Academy of Sciences,
C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
November 1995, Bioorganic & medicinal chemistry,
C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
November 1977, Biochemical pharmacology,
C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
June 1994, Biochemistry,
C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
April 1982, Neuroendocrinology,
C Altomare, and S Cellamare, and L Summo, and M Catto, and A Carotti, and U Thull, and P A Carrupt, and B Testa, and H Stoeckli-Evans
February 2006, Chemistry & biodiversity,
Copied contents to your clipboard!